Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1-EGFR Signaling in a Xenograft Model of CD44+ /CD24low /CD90+ Myoepithelial Cells

Molecular Cancer Research : MCR
Micaela MontanariBianca Maria Veneziani

Abstract

The surface glycoprotein THY is a marker of myoepithelial precursor cells, which are basal cells with epithelial-mesenchymal intermediate phenotype originating from the ectoderm. Myoepithelial precursor cells are lost during progression from in situ to invasive carcinoma. To define the functional role of Thy1-positive cells within the myoepithelial population, we tracked Thy1 expression in human breast cancer samples, isolated THY1-positive myoepithelial progenitor cells (CD44+/CD24low/CD90+), and established long-term cultures (parental cells). Parental cells were used to generate a xenograft model to examine Thy1 expression during tumor formation. Post-transplantation cell cultures lost THY1 expression through methylation at the THY1 locus and this is associated with an increase in EGFR and NOTCH1 transcript levels. Thy1-low cells are sensitive to the EGFR/HER2 dual inhibitor lapatinib. High THY1 expression is associated with poorer relapse-free survival in patients with breast cancer. THY1 methylation may track the shift of bipotent progenitors into differentiated cells. Thy1 is a good candidate biomarker in basal-like breast cancer. IMPLICATIONS: Our findings provide evidence that THY1 expression is lost in xenografts due t...Continue Reading

References

Jul 1, 1986·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R B NagleE D Jarasch
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T SekiJ Silver
May 1, 1984·Immunobiology·L BonewaldE W Ades
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R C Gupta
Jan 1, 1993·Breast Cancer Research and Treatment·C C BenzC K Osborne
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 24, 2004·Cancer Genetics and Cytogenetics·Harindra R AbeysingheNancy Wang
Jul 15, 2004·The American Journal of Surgical Pathology·Melinda F Lerwill
Jul 21, 2004·Cancer Cell·Minna AllinenKornelia Polyak
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Nov 13, 2004·Breast Cancer Research : BCR·Gabriela DontuMax S Wicha
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Jun 30, 2006·Journal of Mammary Gland Biology and Neoplasia·Kornelia Polyak, Min Hu
Jun 30, 2006·Journal of Mammary Gland Biology and Neoplasia·Sanford H Barsky, Nina J Karlin
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
May 6, 2008·Cancer Cell·Min HuKornelia Polyak
Oct 23, 2008·Cell Stem Cell·Toula BourasJane E Visvader
Nov 11, 2008·Experimental Cell Research·Karl R Schmitz, Kathryn M Ferguson
Nov 15, 2008·The Journal of Pathology·J Stingl
Feb 3, 2009·Cell and Tissue Banking·Agostina NardoneBianca Maria Veneziani
Feb 17, 2009·Cancer Investigation·Jianjian DaiChunyan Ji
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani
Sep 4, 2010·Breast Cancer Research : BCR·Aleix PratCharles M Perou
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Oct 18, 2011·Cell·Scott Valastyan, Robert A Weinberg
Jul 14, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Felicia LecciaBianca Maria Veneziani
Nov 20, 2012·The American Journal of Pathology·Kathleen SchubertAnja Saalbach
Aug 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members

❮ Previous
Next ❯

Citations

May 19, 2021·Molecular Carcinogenesis·Sung-Hyun HwangYongbaek Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.